This volume explores developments in avenues of therapy for the treatment of asthma and respiratory infections. It includes chapters on interferons, ICAM-1 receptor blockades, vaccines, and mediator antagonists. The text also classifies and describes a range of acute respiratory infections, common infectious agents, and risk factors associated with severe and fatal respiratory infection (ARI).